ETF health check: testing the pulse of June 2016's hottest launches
A year on we reveal the ETFs that have seen assets swell as well as those that have failed to gain traction.
Four wealth managers on the role of ETFs
As exchange traded funds become an increasingly important cog in the investment wheel, we ask four wealth managers what role they play in their asset allocation.
ETF worries: capacity or liquidity?
The problem with capacity is you may get too large for the market; with liquidity that the market can move against you
Source launches Europe ex-UK ETF
In a response to the strengthening of European markets Source has launched a new Europe ex-UK exchange traded fund (ETF).
Lyxor slashes fees on European ETFs by more than 50%
Lyxor has the cut the fees on three of its Euro Stoxx exchange-traded funds (ETF) by over 50%.
Crazy in ETF love? New study imagines bottling star quality
Yes sir, they're cut from a different cloth, academics at the University of Zurich and MIT offer an alternative way to reach for the stars, passively.
Lyxor slashes fees on 10-strong sector ETF range
Lyxor cut the fee on its ten world sector exchange-traded fund (ETF).
Perfect blend: how seven DFMs mix active and passive strategies
We spoke to CIOs and heads of research to get an insight on their current positioning and how they blend passive and active strategies.
Invesco PowerShares lists US value ETF
The PowerShares S&P 500 QVM UCITS ETF will seek to replicate the S&P 500 quality, value & momentum multi-factor index.
Coombs: 'blunt tool' passive beta no use for risks ahead
David Coombs has come out firmly against passive investment calling it a ‘blunt tool’ and ‘riskier than active.’
IBT's Craig on the Trump impact for biotech
Ailsa Craig of the International Biotechnology trust highlights the M&A activity seen in the biotechnology sector this year.
How should research be priced in a post-Mifid II world?
Being Mifid II-ready has become a competitive advantage which will set firms apart, according to Brij Malkan from BCA research.
Can refundable performance fees work?
Orbis Investments is the traditional percentage of assets-based fees but it may be ttoo early to tell if the new structure is working
The trials and tribulations of living through M&A
Plenty is written about the impact of the frequent merger and acquisition activity in wealth management on clients, but what about the staff involved?